Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05714059 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
NCT05714059: Completed NA study, sponsored by Medtronic MiniMed.
NCT05714059 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05714059, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
Study Summary
The purpose of this study is to confirm the safety and effectiveness of the MiniMed 780G insulin pump used in combination with the DS5 CGM in type 1 diabetes adult and pediatric subjects in a home setting.
Interventions
- DEVICE Insulin Pump with Continuous Glucose Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-02-28 |
| Est. Completion | 2023-12-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05714059
The ClinicalTrials.gov registry entry for NCT05714059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Insulin Pump with Continuous Glucose Monitoring is the first listed.
NCT05714059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05714059 about?
NCT05714059 is a clinical study titled "Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM". The purpose of this study is to confirm the safety and effectiveness of the MiniMed 780G insulin pump used in combination with the DS5 CGM in type 1 diabetes adult and pediatric subjects in a home setting.
What is the current status of trial NCT05714059?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2023-02-28. Estimated completion is 2023-12-29.
What interventions are being tested in trial NCT05714059?
The interventions under investigation include: Insulin Pump with Continuous Glucose Monitoring (DEVICE).
Who is sponsoring clinical trial NCT05714059?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.